ANELLOBRICKS Trademark

Trademark Overview

On Wednesday, February 16, 2022, a trademark application was filed for ANELLOBRICKS with the United States Patent and Trademark Office. The USPTO has given the ANELLOBRICKS trademark a serial number of 97269409. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, November 1, 2024. This trademark is owned by Ring Therapeutics, Inc.. The ANELLOBRICKS trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of anelloviruses

Product development for others in the field of biotechnology and development of pharmaceuticals, therapeutic agents, and anelloviruses; research and development of therapeutics related to anelloviruses
anellobricks

General Information

Serial Number97269409
Word MarkANELLOBRICKS
Filing DateWednesday, February 16, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, November 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements

Goods and ServicesCustom manufacture of anelloviruses
Goods and ServicesProduct development for others in the field of biotechnology and development of pharmaceuticals, therapeutic agents, and anelloviruses; research and development of therapeutics related to anelloviruses

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, January 25, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 22, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRing Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameRing Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Thursday, December 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 1, 2022ASSIGNED TO EXAMINER
Thursday, December 1, 2022NON-FINAL ACTION WRITTEN
Thursday, December 1, 2022NON-FINAL ACTION E-MAILED
Tuesday, January 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 27, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 27, 2023SOU EXTENSION 1 FILED
Friday, October 27, 2023SOU EXTENSION 1 GRANTED
Tuesday, October 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Tuesday, December 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 26, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 26, 2024SOU EXTENSION 2 GRANTED
Friday, April 26, 2024SOU EXTENSION 2 FILED
Friday, November 1, 2024SOU TEAS EXTENSION RECEIVED
Friday, November 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 1, 2024SOU EXTENSION 3 FILED
Friday, November 1, 2024SOU EXTENSION 3 GRANTED
Saturday, April 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

anellobricks development anelloviruses therapeutic agents research therapeutics related pharmaceuticals field manufacture